| microRNA-7 (miR-7) is a potential tumor suppressor in glioblastoma targeting critical cancer pathways | glioblastoma, |
| miR-7 functions as a tumor suppressor and plays a substantial role in inhibiting the tumorigenesis and reversing the metastasis of hepatocellular carcinoma through the PI3K/Akt/mTOR-signaling pathway in vitro and in vivo. | liver, |
| miR-7-5p may represent a novel tumor suppressor miRNA in melanoma, acting at least in part via its inhibition of IRS-2 expression and oncogenic Akt signaling. | skin, |
| miR-7-5p may represent a novel tumor suppressor miRNA in melanoma, acting at least in part via its inhibition of IRS-2 expression and oncogenic Akt signaling.[mirna-7-5p] | skin, |
| MiR-7 is a novel miRNA with tumor suppressive function in colon cancer by targeting oncogenic YY1. | colorectal, |
| These data suggest that miR-7-5p functions as a tumor suppressor gene to regulate glioblastoma microvascular endothelial cell proliferation potentially by targeting the RAF1 oncogene | glioblastoma, |
| MiR-7 Functions as a Tumor Suppressor by Targeting the Oncogenes TAL1 in T-Cell Acute Lymphoblastic Leukemia | leukemia, |
| miR-7 exerts tumor-suppressive effects in hepatocarcinogenesis through the suppression of oncogene CCNE1 expression. | None |
| overexpression of ciRS-7 blocked the miR-7-induced tumor suppression in MGC-803 and HGC-27 cells and led to a more aggressive oncogenic phenotype, via antagonizing miR-7-mediated PTEN/PI3K/AKT pathway. | None |
| EGFR promotes lung tumorigenesis by activating miR-7 through a Ras/ERK/Myc pathway that targets the Ets2 transcriptional repressor ERF. | lung, |
| Identification of miR-7 as an oncogene in renal cell carcinoma. | kidney, |